Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor maintenance update and does not affect study content or eligibility details.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page shows a minor site revision from v3.4.0 to v3.4.1 with no changes to the study content, eligibility criteria, or reported outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page adds a Locations section listing study sites in California, New Jersey, Pennsylvania, and Rio Grande do Sul, Brazil, and records revision v3.3.3. The previous location blocks are removed or reorganized.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 on the page. This appears to be a minor versioning update that does not change study content or functionality.SummaryDifference0.1%

- Check99 days agoChange DetectedThe government funding lapse notice was removed from the page. The study details and related content remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.